9-anilinoacridine has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baguley, BC; Jacintho, JD; Kovacic, P; Wakelin, LP | 1 |
| Bacherikov, VA; Chen, CH; Chou, TC; Dong, HJ; Lee, RZ; Lin, YW; Liu, LF; Su, TL; Tsai, TJ; Zhang, X | 1 |
1 review(s) available for 9-anilinoacridine and Neoplasms
| Article | Year |
|---|---|
Mechanisms of action of DNA intercalating acridine-based drugs: how important are contributions from electron transfer and oxidative stress?
Topics: Acridines; Amsacrine; Antineoplastic Agents; DNA; Electron Transport; Humans; Intercalating Agents; Neoplasms; Oxidative Stress | 2003 |
1 other study(ies) available for 9-anilinoacridine and Neoplasms
| Article | Year |
|---|---|
Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity.
Topics: Alkylating Agents; Amsacrine; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Neoplasms; Remission Induction; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2005 |